HealthEquity, Inc. (NASDAQ:HQY) Given Consensus Recommendation of “Moderate Buy” by Brokerages

HealthEquity, Inc. (NASDAQ:HQY) has received an average rating of “Moderate Buy” from the fourteen ratings firms that are covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating and thirteen have issued a buy rating on the company. The average 12 month price target among brokers that have covered the stock in the last year is $110.71.

A number of equities research analysts recently commented on HQY shares. BTIG Research increased their price target on HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a research report on Thursday, November 14th. JMP Securities raised their target price on HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research note on Tuesday, December 10th. Barrington Research upped their price target on shares of HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research report on Monday, December 2nd. Mizuho assumed coverage on shares of HealthEquity in a research report on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price objective for the company. Finally, Royal Bank of Canada upped their target price on shares of HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 10th.

HealthEquity Stock Up 1.0 %

Shares of NASDAQ HQY opened at $108.80 on Thursday. HealthEquity has a 52-week low of $65.01 and a 52-week high of $111.36. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The business has a fifty day moving average of $99.85 and a two-hundred day moving average of $88.02. The stock has a market cap of $9.43 billion, a PE ratio of 99.82, a PEG ratio of 1.86 and a beta of 0.54.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same quarter in the prior year, the company earned $0.40 EPS. As a group, equities research analysts expect that HealthEquity will post 2.32 earnings per share for the current fiscal year.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of the stock in a transaction on Monday, December 9th. The shares were sold at an average price of $101.56, for a total value of $837,870.00. Following the sale, the director now directly owns 66,469 shares in the company, valued at approximately $6,750,591.64. This trade represents a 11.04 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Frank Corvino sold 1,039 shares of HealthEquity stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total transaction of $99,847.90. Following the transaction, the director now directly owns 3,784 shares in the company, valued at approximately $363,642.40. This represents a 21.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 34,289 shares of company stock worth $3,355,718. Insiders own 2.20% of the company’s stock.

Institutional Trading of HealthEquity

Several hedge funds have recently added to or reduced their stakes in HQY. UMB Bank n.a. lifted its stake in HealthEquity by 65.6% in the fourth quarter. UMB Bank n.a. now owns 414 shares of the company’s stock valued at $40,000 after buying an additional 164 shares in the last quarter. Paladin Wealth LLC bought a new stake in HealthEquity in the 3rd quarter valued at $39,000. Point72 Asia Singapore Pte. Ltd. acquired a new position in HealthEquity in the 2nd quarter worth $73,000. GAMMA Investing LLC increased its holdings in HealthEquity by 57.8% during the 3rd quarter. GAMMA Investing LLC now owns 939 shares of the company’s stock worth $77,000 after purchasing an additional 344 shares in the last quarter. Finally, Quarry LP raised its stake in shares of HealthEquity by 418.8% in the 3rd quarter. Quarry LP now owns 1,349 shares of the company’s stock valued at $110,000 after purchasing an additional 1,089 shares during the period. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.